143 related articles for article (PubMed ID: 20649898)
1. Clinicopathological significance and prognostic value of leukemia-related protein 16 expression in invasive ductal breast carcinoma.
Zhao P; Lu Y; Han W
Cancer Sci; 2010 Oct; 101(10):2262-8. PubMed ID: 20649898
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of LRP16 gene in human breast cancer].
Liao DX; Han WD; Zhao YL; Pu YD; Mu YM; Luo CH; Li XH
Ai Zheng; 2006 Jul; 25(7):866-70. PubMed ID: 16831279
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
Zhao P; Lu Y; Jiang X; Li X
Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
[TBL] [Abstract][Full Text] [Related]
4. [Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof].
Wang ZB; Zhao P; Liu M; Li XH
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2171-6. PubMed ID: 17064501
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma.
Erdem O; Dursun A; Coşkun U; Günel N
Tumori; 2005; 91(1):46-52. PubMed ID: 15850004
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
[TBL] [Abstract][Full Text] [Related]
7. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
[TBL] [Abstract][Full Text] [Related]
8. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
Falco M
Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance and prognostic value of LRP16 expression in colorectal carcinoma.
Xi HQ; Zhao P; Han WD
World J Gastroenterol; 2010 Apr; 16(13):1644-8. PubMed ID: 20355243
[TBL] [Abstract][Full Text] [Related]
10. [Loss of fragile histidine triad expression and metastasis in breast cancer].
Zhao P; Li XY; Chen LZ
Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
[TBL] [Abstract][Full Text] [Related]
11. Correlation between expression of LRP16, Ki67 and EGFR and breast cancer clinical pathologic factors and prognosis.
Yao DJ; Qiao S; Zhang Y; Zhao YT; Yuan CH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):47-51. PubMed ID: 28745792
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract][Full Text] [Related]
13. [Her2-Neu expression in ductal adenocarcinomas of the breast gland: correlation with histopathological parameters and estrogen receptors' expression in Mexican patients].
Brück P; Vilches Cisneros N; Ramos López E; Barboza Quintana O; Ancer Rodríguez J; Flores Gutiérrez JP
Ginecol Obstet Mex; 2006 Oct; 74(10):516-22. PubMed ID: 21961357
[TBL] [Abstract][Full Text] [Related]
14. Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast.
Dai XL; Zhou SL; Qiu J; Liu YF; Hua H
Eur J Gynaecol Oncol; 2012; 33(6):633-9. PubMed ID: 23327061
[TBL] [Abstract][Full Text] [Related]
15. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
[TBL] [Abstract][Full Text] [Related]
16. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
[TBL] [Abstract][Full Text] [Related]
17. Mutual predictive value of c-erbB-2 overexpression and various prognostic factors in ductal invasive breast carcinoma.
Jakić-Razumović J; Petrovecki M; Uzarević B; Gamulin S
Tumori; 2000; 86(1):30-6. PubMed ID: 10778763
[TBL] [Abstract][Full Text] [Related]
18. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.
Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J
Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896
[TBL] [Abstract][Full Text] [Related]
19. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
[TBL] [Abstract][Full Text] [Related]
20. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
El-Gendi SM; Mostafa MF
Pathol Oncol Res; 2016 Jul; 22(3):461-70. PubMed ID: 26597806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]